{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:00:16Z","timestamp":1791090016211,"version":"4.1.0"},"reference-count":206,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1172,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.jhep.2009.11.027","type":"journal-article","created":{"date-parts":[[2010,2,19]],"date-time":"2010-02-19T09:17:55Z","timestamp":1266571075000},"page":"745-758","source":"Crossref","is-referenced-by-count":231,"title":["Primary biliary cirrhosis: A 2010 update"],"prefix":"10.1016","volume":"52","author":[{"given":"Raoul","family":"Poupon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2009.11.027_bib1","first-page":"265","article-title":"On a certain affection of the skin ,vitiligoidea \u2013 a. plana, b. tuberosa","volume":"7","author":"Addison","year":"1851","journal-title":"Guys Hosp Rep"},{"key":"10.1016\/j.jhep.2009.11.027_bib2","first-page":"1","article-title":"Primary biliary cirrhosis","volume":"61","author":"Dauphinee","year":"1949","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.11.027_bib3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00005792-195012000-00002","article-title":"Primary biliary cirrhosis","volume":"29","author":"Ahrens","year":"1950","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jhep.2009.11.027_bib4","first-page":"387","article-title":"Primary biliary cirrhosis. Chronic non-suppurative destructive cholangitis","volume":"46","author":"Rubin","year":"1965","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2009.11.027_bib5","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(65)91372-3","article-title":"Serological tests in diagnosis of primary biliary cirrhosis","volume":"1","author":"Walker","year":"1965","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2009.11.027_bib6","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(82)91327-7","article-title":"ATPase-associated antigen (M2): marker antigen for serological diagnosis of primary biliary cirrhosis","volume":"2","author":"Berg","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2009.11.027_bib7","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.4049\/jimmunol.138.10.3525","article-title":"Identification and specificity of a cDNA encoding the 70kd mitochondrial antigen recognized in primary biliary cirrhosis","volume":"138","author":"Gershwin","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2009.11.027_bib8","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0140-6736(88)91894-6","article-title":"Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens","volume":"1","author":"Yeaman","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2009.11.027_bib9","first-page":"144","article-title":"Liver transplantation for primary biliary cirrhosis","volume":"9","author":"Tzakis","year":"1989","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jhep.2009.11.027_bib10","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM199105303242204","article-title":"A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis","volume":"324","author":"Poupon","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2009.11.027_bib11","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1089-3261(03)00102-8","article-title":"The epidemiology of primary biliary cirrhosis","volume":"7","author":"Prince","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2009.11.027_bib12","first-page":"602A","article-title":"Epidemiology of primary biliary cirrhosis: results of a prospective study performed on the overall metropolitan French population","volume":"48","author":"Corpechot","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib13","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/hep.510270303","article-title":"Characterization of antimitochondrial antibodies in health adults","volume":"27","author":"Mattalia","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib14","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0895-4356(00)00370-X","article-title":"Primary biliary cirrhosis among atomic bomb survivors in Nagasaki, Japan","volume":"54","author":"Ohba","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jhep.2009.11.027_bib15","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/hep.510300213","article-title":"Primary biliary cirrhosis once rare, now common in the United Kingdom?","volume":"30","author":"James","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib16","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/ije\/26.4.830","article-title":"Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England","volume":"26","author":"Metcalf","year":"1997","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jhep.2009.11.027_bib17","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1053\/gast.2000.20197","article-title":"Epidemiology and natural history of primary biliary cirrhosis in a US community","volume":"119","author":"Kim","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.11.027_bib18","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/gut.36.6.927","article-title":"Low prevalence of primary biliary cirrhosis in Victoria, Australia. Melbourne Liver Group","volume":"36","author":"Watson","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2009.11.027_bib19","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1053\/j.gastro.2004.04.064","article-title":"Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations","volume":"127","author":"Sood","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.11.027_bib20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3109\/00365529509093292","article-title":"Primary biliary cirrhosis in Estonia. With special reference to incidence, prevalence, clinical features, and outcome","volume":"30","author":"Remmel","year":"1995","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.11.027_bib21","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/hep.1840110317","article-title":"Epidemiology of primary biliary cirrhosis in a defined rural population in the northern part of Sweden","volume":"11","author":"Danielsson","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib22","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1053\/jhep.2001.29760","article-title":"The geographical distribution of primary biliary cirrhosis in a well-defined cohort","volume":"34","author":"Prince","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib23","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/hep.21076","article-title":"Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites","volume":"43","author":"Ala","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/10446670310001626526","article-title":"Geographic clusters of primary biliary cirrhosis","volume":"10","author":"Abu-Mouch","year":"2003","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.jhep.2009.11.027_bib25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3402\/ijch.v63i0.17896","article-title":"The mystery of primary biliary cirrhosis in British Columbia\u2019s First Nations people","volume":"63","author":"Arbour","year":"2004","journal-title":"Int J Circumpolar Health"},{"key":"10.1016\/j.jhep.2009.11.027_bib26","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0168-8278(05)80137-0","article-title":"Familial primary biliary cirrhosis","volume":"20","author":"Bach","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.11.027_bib27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/jaut.1999.0299","article-title":"Familial primary biliary cirrhosis in Hiroshima","volume":"13","author":"Tsuji","year":"1999","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jhep.2009.11.027_bib28","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0168-8278(99)80097-X","article-title":"Familial primary biliary cirrhosis reassessed: a geographically-based population study","volume":"30","author":"Jones","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.11.027_bib29","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1053\/j.gastro.2004.05.005","article-title":"Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment","volume":"127","author":"Selmi","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.11.027_bib30","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1089-3261(03)00095-3","article-title":"Genetic factors in the pathogenesis of primary biliary cirrhosis","volume":"7","author":"Jones","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2009.11.027_bib31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cld.2008.02.007","article-title":"Genetics and genomics of primary biliary cirrhosis","volume":"12","author":"Juran","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2009.11.027_bib32","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jhep.2009.01.015","article-title":"Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations","volume":"50","author":"Tanaka","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.11.027_bib33","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2008.07.027","article-title":"Genetic factors of susceptibility and of severity in primary biliary cirrhosis","volume":"49","author":"Poupon","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.11.027_bib34","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1056\/NEJMoa0810440","article-title":"Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants","volume":"360","author":"Hirschfield","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2009.11.027_bib35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.smim.2006.07.010","article-title":"Inborn errors of IL-12\/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features","volume":"18","author":"Filipe-Santos","year":"2006","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jhep.2009.11.027_bib36","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/art.24412","article-title":"CTLA4\/ICOS gene variants and haplotypes are associated with rheumatoid arthritis and primary biliary cirrhosis in the Canadian population","volume":"60","author":"Walker","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jhep.2009.11.027_bib37","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1053\/j.gastro.2008.06.077","article-title":"Primary biliary cirrhosis is associated with a genetic variant in the 3\u2032 flanking region of the CTLA4 gene","volume":"135","author":"Juran","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.11.027_bib38","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.cgh.2007.02.012","article-title":"Cytotoxic T-lymphocyte-associated antigen-4 single nucleotide polymorphisms and haplotypes in primary biliary cirrhosis","volume":"5","author":"Donaldson","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2009.11.027_bib39","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1053\/j.gastro.2008.12.040","article-title":"Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium","volume":"136","author":"d\u2019Aldebert","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.11.027_bib40","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1053\/j.gastro.2008.02.020","article-title":"Ae2a,b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis","volume":"134","author":"Salas","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.11.027_bib41","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.20907","article-title":"Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients","volume":"42","author":"Gershwin","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib42","first-page":"299A","article-title":"Case control studies support the association of environmental and genetic risk factors with primary biliary cirrhosis","volume":"42","author":"James","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib43","first-page":"547A","article-title":"Results of the French study of risk factors for primary biliary cirrhosis","volume":"46","author":"Corpechot","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib44","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1053\/he.2000.7050","article-title":"An exploratory population-based case\u2013control study of primary biliary cirrhosis","volume":"31","author":"Howel","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0009-2797(98)00081-7","article-title":"Interindividual variability in P450-dependent generation of neoantigens in halothane hepatitis","volume":"116","author":"Eliasson","year":"1998","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jhep.2009.11.027_bib46","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1021\/tx0002435","article-title":"Indirect cytotoxicity of flucloxacillin toward human biliary epithelium via metabolite formation in hepatocytes","volume":"14","author":"Lakehal","year":"2001","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.jhep.2009.11.027_bib47","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/hep.22540","article-title":"Xenobiotic incorporation into pyruvate dehydrogenase complex can occur via the exogenous lipoylation pathway","volume":"48","author":"Walden","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib48","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.4049\/jimmunol.179.4.2651","article-title":"Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization","volume":"179","author":"Leung","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2009.11.027_bib49","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.4049\/jimmunol.167.5.2956","article-title":"Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis","volume":"167","author":"Long","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2009.11.027_bib50","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2006.06.002","article-title":"Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis","volume":"27","author":"Rieger","year":"2006","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jhep.2009.11.027_bib51","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1365-2249.2008.03837.x","article-title":"Induction of autoimmune cholangitis in non-obese diabetic (NOD).1101 mice following a chemical xenobiotic immunization","volume":"155","author":"Wakabayashi","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jhep.2009.11.027_bib52","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/hep.22390","article-title":"Loss of tolerance in C57BL\/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease","volume":"48","author":"Wakabayashi","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib53","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1053\/jhep.2003.50446","article-title":"Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium","volume":"38","author":"Selmi","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib54","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.chom.2008.03.009","article-title":"Liver autoimmunity triggered by microbial activation of natural killer T cells","volume":"3","author":"Mattner","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jhep.2009.11.027_bib55","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/S0140-6736(05)61042-2","article-title":"Expression of pyruvate-dehydrogenase complex PDC-E2 on biliary epithelial cells induced by lymph nodes from primary biliary cirrhosis","volume":"352","author":"Sadamoto","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2009.11.027_bib56","doi-asserted-by":"crossref","first-page":"8454","DOI":"10.1073\/pnas.1433063100","article-title":"Does a betaretrovirus infection trigger primary biliary cirrhosis?","volume":"100","author":"Xu","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jhep.2009.11.027_bib57","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/j.gastro.2004.05.033","article-title":"Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis","volume":"127","author":"Selmi","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.11.027_bib58","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jhep.2008.10.026","article-title":"Mouse mammary tumour virus-like virus (MMTV-LV) is present within the liver in a wide range of hepatic disorders and unrelated to nuclear p53 expression or hepatocarcinogenesis","volume":"50","author":"Johal","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.11.027_bib59","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2036.2008.03799.x","article-title":"Clinical trial: randomized controlled trial of zidovudine and lamivudine for patients with primary biliary cirrhosis stabilized on ursodiol","author":"Mason","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2009.11.027_bib60","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1084\/jem.20051911","article-title":"NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis","volume":"203","author":"Irie","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2009.11.027_bib61","first-page":"551A","article-title":"Biliary infection with mouse mammary tumor virus in the nod.C3C4 mouse and other mouse models of primary biliary cirrhosis","volume":"46","author":"Chen","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib62","first-page":"998A","article-title":"Mouse mammary tumor virus triggers viral cholangitis in the nod.c3c4 mouse model of primary biliary cirrhosis","volume":"50","author":"Subsin","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib63","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cld.2008.02.011","article-title":"Animal models of primary biliary cirrhosis","volume":"12","author":"Chuang","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2009.11.027_bib64","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/hep.23132","article-title":"Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice","volume":"50","author":"Yoshida","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib65","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jhep.2008.09.010","article-title":"New light on anion exchangers in primary biliary cirrhosis","volume":"49","author":"Beuers","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.11.027_bib66","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/hep.510300410","article-title":"Fetal microchimerism alone does not contribute to the induction of primary biliary cirrhosis","volume":"30","author":"Tanaka","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib67","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0168-8278(00)80298-6","article-title":"Fetal microchimerism in primary biliary cirrhosis","volume":"33","author":"Corpechot","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.11.027_bib68","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S0168-8278(00)80297-4","article-title":"Detection of male DNA in the liver of female patients with primary biliary cirrhosis","volume":"33","author":"Fanning","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.11.027_bib69","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/hep.510300322","article-title":"FISH for Y chromosome in women with primary biliary cirrhosis: lack of evidence for leukocyte microchimerism","volume":"30","author":"Rubbia-Brandt","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib70","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1046\/j.1365-2249.2000.01381.x","article-title":"Blood fetal microchimerism in primary biliary cirrhosis","volume":"122","author":"Invernizzi","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jhep.2009.11.027_bib71","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(04)15541-4","article-title":"Frequency of monosomy X in women with primary biliary cirrhosis","volume":"363","author":"Invernizzi","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2009.11.027_bib72","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1196\/annals.1423.010","article-title":"X monosomy in female systemic lupus erythematosus","volume":"1110","author":"Invernizzi","year":"2007","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.jhep.2009.11.027_bib73","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/hep.21696","article-title":"Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis","volume":"46","author":"Miozzo","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib74","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/hep.1840140307","article-title":"Distribution of dihydrolipoamide acetyltransferase (E2) in the liver and portal lymph nodes of patients with primary biliary cirrhosis: an immunohistochemical study","volume":"14","author":"Joplin","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib75","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0140-6736(92)91001-O","article-title":"Membrane dihydrolipoamide acetyltransferase (E2) on human biliary epithelial cells in primary biliary cirrhosis","volume":"339","author":"Joplin","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2009.11.027_bib76","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1172\/JCI116504","article-title":"Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2","volume":"91","author":"Van de Water","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2009.11.027_bib77","first-page":"1031","article-title":"Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1\/B7 expression","volume":"21","author":"Tsuneyama","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib78","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/hep.510240517","article-title":"Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis","volume":"24","author":"Van de Water","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib79","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0168-8278(21)80008-2","article-title":"Liver allograft rejection \u2013 current concepts on diagnosis and treatment","volume":"23","author":"Neuberger","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.11.027_bib80","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1172\/JCI200110716","article-title":"Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis","volume":"108","author":"Odin","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2009.11.027_bib81","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jaut.2006.11.004","article-title":"T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis","volume":"27","author":"Allina","year":"2006","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jhep.2009.11.027_bib82","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jaut.2007.10.003","article-title":"Anti-CD16 autoantibodies and delayed phagocytosis of apoptotic cells in primary biliary cirrhosis","volume":"30","author":"Allina","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jhep.2009.11.027_bib83","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/hep.20175","article-title":"Caspase induction by IgA antimitochondrial antibody: IgA-mediated biliary injury in primary biliary cirrhosis","volume":"39","author":"Matsumura","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib84","first-page":"460","article-title":"Immunohistochemical detection of bcl-2 protein in normal and pathological human liver","volume":"144","author":"Charlotte","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2009.11.027_bib85","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/s-2007-1007153","article-title":"Dysregulation of apoptosis in the cholangiopathies and cholangiocarcinoma","volume":"18","author":"Celli","year":"1998","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2009.11.027_bib86","first-page":"G749","article-title":"Glutathione depletion is associated with decreased Bcl-2 expression and increased apoptosis in cholangiocytes","volume":"275","author":"Celli","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jhep.2009.11.027_bib87","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00795-006-0321-z","article-title":"Molecular mechanisms of cholangiopathy in primary biliary cirrhosis","volume":"39","author":"Harada","year":"2006","journal-title":"Med Mol Morphol"},{"key":"10.1016\/j.jhep.2009.11.027_bib88","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/hep.510250505","article-title":"Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis","volume":"25","author":"Koga","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib89","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/hep.510290444","article-title":"Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression","volume":"29","author":"Degott","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib90","first-page":"119","article-title":"Expression of antigens related to apoptosis and cell proliferation in chronic nonsuppurative destructive cholangitis in primary biliary cirrhosis","volume":"429","author":"Kuroki","year":"1996","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jhep.2009.11.027_bib91","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jhep.2004.08.022","article-title":"Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis","volume":"41","author":"Alvaro","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.11.027_bib92","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1369\/jhc.6R7125.2006","article-title":"Activation of the IGF1 system characterizes cholangiocyte survival during progression of primary biliary cirrhosis","volume":"55","author":"Onori","year":"2007","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.jhep.2009.11.027_bib93","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/hep.20582","article-title":"Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts","volume":"41","author":"Isse","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib94","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/hep.22102","article-title":"Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells","volume":"47","author":"Shimoda","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib95","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00281-009-0167-2","article-title":"Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis","volume":"31","author":"Borchers","year":"2009","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jhep.2009.11.027_bib96","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2249.2009.03947.x","article-title":"Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis","volume":"157","author":"Harada","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jhep.2009.11.027_bib97","article-title":"CX3CL1 (fractalkine): a signpost for biliary inflammation in primary biliary cirrhosis","author":"Shimoda","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib98","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jaut.2008.11.001","article-title":"Hepatic IL-17 responses in human and murine primary biliary cirrhosis","volume":"32","author":"Lan","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jhep.2009.11.027_bib99","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1096\/fj.01-0088com","article-title":"CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB\/AP-1 signaling in human intrahepatic biliary epithelial cells","volume":"15","author":"Afford","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.jhep.2009.11.027_bib100","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1053\/j.gastro.2006.07.023","article-title":"Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver","volume":"132","author":"Alvaro","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.11.027_bib101","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.mam.2007.09.007","article-title":"New insights on the molecular and cell biology of human cholangiopathies","volume":"29","author":"Alvaro","year":"2008","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.jhep.2009.11.027_bib102","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1749-6632.1965.tb19001.x","article-title":"Immune processes in the pathogenesis of liver disease","volume":"124","author":"Popper","year":"1965","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.jhep.2009.11.027_bib103","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/0016-5085(85)90001-0","article-title":"Sequential and diagnostic features in primary biliary cirrhosis based on serial histologic study in 209 patients","volume":"88","author":"Portmann","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.11.027_bib104","first-page":"357","article-title":"Semiquantitative assessment of cholestasis and lymphocytic piecemeal necrosis in primary biliary cirrhosis: a histologic and immunohistochemical study","volume":"12","author":"Nakanuma","year":"1990","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jhep.2009.11.027_bib105","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/gast.2002.31880","article-title":"Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients","volume":"122","author":"Corpechot","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.11.027_bib106","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI30542","article-title":"Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ","volume":"117","author":"Iredale","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2009.11.027_bib107","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/labinvest.3780073","article-title":"PDGF-mediated chemoattraction of hepatic stellate cells by bile duct segments in cholestatic liver injury","volume":"80","author":"Kinnman","year":"2000","journal-title":"Lab Invest"},{"key":"10.1016\/j.jhep.2009.11.027_bib108","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/01.LAB.0000054178.01162.E4","article-title":"The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis","volume":"83","author":"Kinnman","year":"2003","journal-title":"Lab Invest"},{"key":"10.1016\/j.jhep.2009.11.027_bib109","doi-asserted-by":"crossref","first-page":"22986","DOI":"10.1074\/jbc.M412371200","article-title":"Portal fibroblasts regulate the proliferation of bile duct epithelia via expression of NTPDase2","volume":"280","author":"Jhandier","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2009.11.027_bib110","doi-asserted-by":"crossref","first-page":"G765","DOI":"10.1152\/ajpgi.00308.2005","article-title":"Secretion of MCP-1\/CCL2 by bile duct epithelia induces myofibroblastic transdifferentiation of portal fibroblasts","volume":"290","author":"Kruglov","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2009.11.027_bib111","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/hep.21660","article-title":"Bile ductules and stromal cells express hedgehog ligands and\/or hedgehog target genes in primary biliary cirrhosis","volume":"45","author":"Jung","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib112","first-page":"3331","article-title":"Hedgehog signaling regulates epithelial\u2013mesenchymal transition during biliary fibrosis in rodents and humans","volume":"118","author":"Omenetti","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2009.11.027_bib113","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/hep.23019","article-title":"Repair-related activation of hedgehog signaling promotes cholangiocyte chemokine production","volume":"50","author":"Omenetti","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib114","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0016-5085(76)80492-1","article-title":"Cyclic AMP in secretin choleresis. Evidence for a regulatory role in man and baboons but not in dogs","volume":"70","author":"Levine","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.11.027_bib115","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1053\/jhep.2002.32712","article-title":"Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha","volume":"35","author":"Alpini","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib116","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-2002-34502","article-title":"Regulation of cholangiocyte secretion","volume":"22","author":"Fitz","year":"2002","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2009.11.027_bib117","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1053\/j.gastro.2007.08.071","article-title":"Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion","volume":"133","author":"Fiorotto","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.11.027_bib118","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep.510250104","article-title":"Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis","volume":"25","author":"Medina","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib119","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1053\/jhep.2002.33634","article-title":"Defective regulation of cholangiocyte Cl\u2212\/HCO3(\u2212) and Na+\/H+ exchanger activities in primary biliary cirrhosis","volume":"35","author":"Melero","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib120","doi-asserted-by":"crossref","first-page":"117511","DOI":"10.1016\/S0016-5085(03)01201-0","article-title":"Loss of inositol 1,4,5-trisphosphate receptors from bile duct epithelia is a common event in cholestasis","volume":"125","author":"Shibao","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.11.027_bib121","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1053\/gast.2001.25516","article-title":"Proinflammatory cytokines inhibit secretion in rat bile duct epithelium","volume":"121","author":"Spirli","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.11.027_bib122","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1053\/jhep.2001.25086","article-title":"Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis","volume":"33","author":"Sakisaka","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib123","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/gast.2003.50100","article-title":"Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes","volume":"124","author":"Spirli","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.11.027_bib124","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0016-5085(99)70564-0","article-title":"Assessment of biliary bicarbonate secretion in humans by positron emission tomography","volume":"117","author":"Prieto","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.11.027_bib125","first-page":"446","article-title":"A review of defensins of diverse origins","volume":"8","author":"Wong","year":"2007","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.jhep.2009.11.027_bib126","doi-asserted-by":"crossref","first-page":"G377","DOI":"10.1152\/ajpgi.00147.2005","article-title":"On the role and fate of LPS-dephosphorylating activity in the rat liver","volume":"290","author":"Tuin","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2009.11.027_bib127","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0168-8278(98)80058-5","article-title":"Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis","volume":"29","author":"Sasatomi","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.11.027_bib128","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jaut.2003.11.002","article-title":"Immune response to lipopolysaccharide in primary biliary cirrhosis and autoimmune diseases","volume":"22","author":"Ballot","year":"2004","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jhep.2009.11.027_bib129","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1478-3231.2007.01506.x","article-title":"Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis","volume":"27","author":"Zollner","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2009.11.027_bib130","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0168-8278(03)00096-5","article-title":"Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis","volume":"38","author":"Zollner","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.11.027_bib131","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1053\/jhep.2001.22646","article-title":"Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases","volume":"33","author":"Zollner","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib132","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/gut.20.2.137","article-title":"Serum bilirubin: a prognostic factor in primary biliary cirrhosis","volume":"20","author":"Shapiro","year":"1979","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2009.11.027_bib133","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0016-5085(80)90571-5","article-title":"Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients","volume":"78","author":"Christensen","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.11.027_bib134","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1053\/gast.2002.36027","article-title":"Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years","volume":"123","author":"Prince","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.11.027_bib135","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/hep.510230108","article-title":"Time course of histological progression in primary biliary cirrhosis","volume":"23","author":"Locke","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib136","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1053\/jhep.2000.20240","article-title":"The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis","volume":"32","author":"Corpechot","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib137","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/0016-5085(89)90526-X","article-title":"Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history, and influence on survival","volume":"96","author":"Gores","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.11.027_bib138","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/hep.510290301","article-title":"Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis","volume":"29","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib139","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4065\/72.12.1137","article-title":"Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis","volume":"72","author":"Lindor","year":"1997","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jhep.2009.11.027_bib140","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.gastro.2004.11.009","article-title":"The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis","volume":"128","author":"Corpechot","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.11.027_bib141","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","article-title":"Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid","volume":"130","author":"Pares","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.11.027_bib142","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22428","article-title":"Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis","volume":"48","author":"Corpechot","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib143","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1053\/j.gastro.2009.01.003","article-title":"Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid","volume":"136","author":"Kuiper","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.11.027_bib144","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S1089-3261(03)00092-8","article-title":"Autoimmune overlapping syndromes","volume":"7","author":"Poupon","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2009.11.027_bib145","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/gut.49.2.276","article-title":"Jaundice in non-cirrhotic primary biliary cirrhosis: the premature ductopenic variant","volume":"49","author":"Vleggaar","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2009.11.027_bib146","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00042737-200503000-00015","article-title":"Fatigue is not a specific symptom in patients with primary biliary cirrhosis","volume":"17","author":"Bjornsson","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2009.11.027_bib147","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/gut.43.5.705","article-title":"Fatigue in primary biliary cirrhosis","volume":"43","author":"Cauch-Dudek","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2009.11.027_bib148","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1572-0241.2000.01857.x","article-title":"Impact of fatigue on the quality of life of patients with primary biliary cirrhosis","volume":"95","author":"Huet","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.11.027_bib149","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1136\/gut.2005.065862","article-title":"Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis","volume":"54","author":"Jacoby","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2009.11.027_bib150","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/hep.20276","article-title":"Quality of life in patients with primary biliary cirrhosis","volume":"40","author":"Poupon","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib151","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1053\/gast.2002.32993","article-title":"The true impact of fatigue in primary biliary cirrhosis: a population study","volume":"122","author":"Goldblatt","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.11.027_bib152","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cld.2008.02.010","article-title":"Fatigue in primary biliary cirrhosis","volume":"12","author":"Newton","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2009.11.027_bib153","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jhep.2007.01.036","article-title":"Depression in patients with primary biliary cirrhosis and primary sclerosing cholangitis","volume":"46","author":"van Os","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.11.027_bib154","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/hep.21229","article-title":"Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis","volume":"44","author":"Poupon","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib155","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1194\/jlr.M400229-JLR200","article-title":"Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation","volume":"45","author":"Chang","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2009.11.027_bib156","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0168-8278(99)80098-1","article-title":"Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis. UDCA-PBC Group","volume":"30","author":"Poupon","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.11.027_bib157","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1478-3231.2004.0918.x","article-title":"Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis","volume":"24","author":"Corpechot","year":"2004","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2009.11.027_bib158","doi-asserted-by":"crossref","unstructured":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009;51:237\u2013267.","DOI":"10.1016\/j.jhep.2009.04.009"},{"key":"10.1016\/j.jhep.2009.11.027_bib159","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib160","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/0016-5085(93)90160-E","article-title":"Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis","volume":"105","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.11.027_bib161","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0016-5085(90)91247-4","article-title":"Antibodies against mitochondrial dehydrogenase complexes in primary biliary cirrhosis","volume":"99","author":"Yoshida","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.11.027_bib162","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/hep.22380","article-title":"Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis","volume":"48","author":"O\u2019Brien","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib163","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1053\/jhep.2001.27562","article-title":"Autoimmune hepatitis with incidental histologic features of bile duct injury","volume":"34","author":"Czaja","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib164","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/j.1478-3231.2007.01538.x","article-title":"Development of autoimmune hepatitis in primary biliary cirrhosis","volume":"27","author":"Gossard","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2009.11.027_bib165","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouilleres","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib166","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cld.2008.02.005","article-title":"Osteoporosis in primary biliary cirrhosis: pathogenesis and treatment","volume":"12","author":"Pares","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2009.11.027_bib167","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0016-5085(97)70183-5","article-title":"Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis","volume":"113","author":"Poupon","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.11.027_bib168","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/hep.510290603","article-title":"Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group","volume":"29","author":"Poupon","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib169","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1111\/j.1572-0241.2006.00699.x","article-title":"Prognosis of ursodeoxycholic acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients","volume":"101","author":"ter Borg","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.11.027_bib170","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.cgh.2007.07.015","article-title":"Transplantation trends in primary biliary cirrhosis","volume":"5","author":"Lee","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2009.11.027_bib171","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/hep.21871","article-title":"Geotherapeutics of primary biliary cirrhosis: bright and sunny around the Mediterranean but still cloudy and foggy in the United Kingdom","volume":"46","author":"Corpechot","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib172","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/thy.2007.0255","article-title":"Bile acids and the membrane bile acid receptor TGR5 \u2013 connecting nutrition and metabolism","volume":"18","author":"Thomas","year":"2008","journal-title":"Thyroid"},{"key":"10.1016\/j.jhep.2009.11.027_bib173","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0016-5085(99)70351-3","article-title":"Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial","volume":"117","author":"Leuschner","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.11.027_bib174","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hep.20646","article-title":"Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: a three-year randomized trial","volume":"41","author":"Rautiainen","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib175","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0016-5085(99)70403-8","article-title":"A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis","volume":"117","author":"Kaplan","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.11.027_bib176","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1365-2036.2006.03048.x","article-title":"Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy","volume":"24","author":"Babatin","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2009.11.027_bib177","first-page":"1158","article-title":"The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study","volume":"22","author":"Lindor","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib178","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0168-8278(97)80294-2","article-title":"The combination of ursodeoxycholic acid and methotrexate for primary biliary cirrhosis is not better than ursodeoxycholic acid alone","volume":"27","author":"Gonzalez-Koch","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2009.11.027_bib179","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/hep.20897","article-title":"Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis","volume":"42","author":"Combes","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib180","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/hep.20103","article-title":"A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: ten-year results","volume":"39","author":"Kaplan","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib181","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM199005173222003","article-title":"A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis","volume":"322","author":"Wiesner","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2009.11.027_bib182","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0016-5085(93)90422-9","article-title":"Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial","volume":"104","author":"Lombard","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.11.027_bib183","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1124\/dmd.105.008748","article-title":"Inhibition of bile acid transport across Na+\/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs","volume":"34","author":"Mita","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jhep.2009.11.027_bib184","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1386-6346(02)00170-5","article-title":"Hydrophilic bile salts have a cytoprotective effect against cyclosporine A-induced cholestasis through enhanced canalicular membrane fluidity and transporter activity","volume":"25","author":"Tsuboi","year":"2003","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2009.11.027_bib185","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cld.2008.02.008","article-title":"Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents","volume":"12","author":"Silveira","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2009.11.027_bib186","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1055\/s-2005-916326","article-title":"Future treatment options in PBC","volume":"25","author":"Vierling","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2009.11.027_bib187","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1872-034X.2007.00305.x","article-title":"The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: a prospective, multicenter study","volume":"38","author":"Iwasaki","year":"2008","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2009.11.027_bib188","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/hep.22670","article-title":"Comment on biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis","volume":"49","author":"Walker","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib189","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/j.gastro.2009.06.027","article-title":"Targeting farnesoid x receptor in hepatic and biliary inflammatory diseases","volume":"137","author":"Chignard","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.11.027_bib190","doi-asserted-by":"crossref","DOI":"10.1002\/hep.23238","article-title":"B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice","author":"Moritoki","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib191","first-page":"550A","article-title":"Rituximab for primary biliary cirrhosis (PBC) refractory to ursodeoxycholic acid (UDCA)","volume":"46","author":"Myers","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib192","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1053\/j.gastro.2007.04.007","article-title":"Glucagon-like peptide-1 and its receptor agonist exendin-4 modulate cholangiocyte adaptive response to cholestasis","volume":"133","author":"Marzioni","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2009.11.027_bib193","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1136\/gut.2008.150870","article-title":"Exendin-4, a glucagon-like peptide 1 receptor agonist, protects cholangiocytes from apoptosis","volume":"58","author":"Marzioni","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2009.11.027_bib194","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S1089-3261(03)00099-0","article-title":"Liver transplantation for primary biliary cirrhosis","volume":"7","author":"MacQuillan","year":"2003","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2009.11.027_bib195","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1432-2277.2008.00729.x","article-title":"Autoimmune liver diseases and recurrence after orthotopic liver transplantation: what have we learned so far?","volume":"22","author":"Schreuder","year":"2009","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhep.2009.11.027_bib196","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-2362.2000.00606.x","article-title":"Effect of cholestyramine on bile acid pattern and synthesis during administration of ursodeoxycholic acid in man","volume":"30","author":"Rust","year":"2000","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jhep.2009.11.027_bib197","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1478-3231.2006.01326.x","article-title":"Rifampin is safe for treatment of pruritus due to chronic cholestasis: a meta-analysis of prospective randomized-controlled trials","volume":"26","author":"Khurana","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2009.11.027_bib198","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/j.1572-0241.2007.01200.x","article-title":"The efficacy and safety of bile acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus","volume":"102","author":"Tandon","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2009.11.027_bib199","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/gut.50.3.436","article-title":"Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis","volume":"50","author":"Prince","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2009.11.027_bib200","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cld.2008.02.013","article-title":"Pruritus in primary biliary cirrhosis: pathogenesis and therapy","volume":"12","author":"Bergasa","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2009.11.027_bib201","doi-asserted-by":"crossref","first-page":"546","DOI":"10.7326\/0003-4819-143-7-200510040-00024","article-title":"Modafinil for the treatment of fatigue in primary biliary cirrhosis","volume":"143","author":"Kaplan","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2009.11.027_bib202","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2036.2006.03223.x","article-title":"An open study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis","volume":"25","author":"Jones","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2009.11.027_bib203","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/hep.1840170408","article-title":"Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis","volume":"17","author":"Poupon","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2009.11.027_bib204","first-page":"890","article-title":"Experimental use of pravastatin in patients with primary biliary cirrhosis associated with hypercholesterolemia","volume":"15","author":"Kurihara","year":"1993","journal-title":"Clin Ther"},{"key":"10.1016\/j.jhep.2009.11.027_bib205","article-title":"Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment","author":"Stojakovic","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jhep.2009.11.027_bib206","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/hep.21907","article-title":"Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis","volume":"46","author":"Garcia-Tsao","year":"2007","journal-title":"Hepatology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827810000279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827810000279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T09:30:52Z","timestamp":1685439052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827810000279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":206,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0168827810000279"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2009.11.027","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}